. . . . . "Zaleplon" . . . "sleep disorder" . . . . . . "Melatonin (97%), trazodone (81%), and quetiapine (73%) were rated by a majority of respondents as effective. Doxepin, zaleplon, tricyclic antidepressants, zolpidem, or lorazepam were rarely prescribed due to lack of evidence and/or concerns about adverse effects, long-term safety, suitability for youth, suicidality, and dependence/tolerance." . . . . . . . "Children and adolescents" . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" . "FkhwQlNlGcgwZoiWALbGOLRgw4LDeEiywONuNJvj9+eC9p+59Cj+MKl2P9PhC2fknFdXIYydK8kV/VySefF/fi52mwvRjVKaadMYuruE04yLbbW5z6LbXdg76IQAoyD3lwlGheZFTXcFz2TkrEfDCQ3kL3l6rwmpTTE+7ZuWj8o=" . . "2022-09-16T11:46:55.051999"^^ . . . "2.3.0" .